← Oncology Approval Tracker

FDA DECISION ·

Kimmtrak

tebentafusp-tebn · Immunocore

FDA approvalNew therapyUveal melanoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Adults with HLA-A*02:01-positive uveal melanoma that is unresectable or metastatic.

LAMPGEN ANALYSIS

Why it matters

A gp100-directed T-cell engager introduces an HLA-selected treatment for advanced uveal melanoma.

What research teams should watch

Confirm HLA typing before referral and plan the required monitoring during initial infusions.

Related study operations checklist

See the staffing responsibilities, timing, and handoff questions for this study setting.

HLA-selected metastatic uveal melanoma

PRIMARY RECORDS

Sources